About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Advances in Heart Failure Treatment: How Safe and Effective Is Vericiguat Based on the VICTORIA Trial? What Do We Know About the Omecamtiv Mecarbil Drug in Development?
By
26th Annual San Diego Heart Failure Symposium
FEATURING
Barry Greenberg
By
26th Annual San Diego Heart Failure Symposium
FEATURING
Barry Greenberg
373 views
December 16, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Related Content
AUTOPLAY
ON
Medical College of Georgia - Augusta University
Cardiovascular Summit at Kiawah 2024
Thu, Jul 18, 2024
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
27:14
MUSC Cardiology
Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…
Feat.
R. Mentz
13:07
Michelle Kittleson
2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …
09:52
AHA 2022 Conference Coverage
AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…
Feat.
R. Mentz
29:08
Scripps Health
Case Presentation: Complex PCI with IABP
Feat.
R. Khedraki,
T. Heywood,
R. Mohan,
A. Srivastava
15:47
Scripps Health
HFpEF in Women
Feat.
B. Borlaug
35:16
Scripps Health
HFpEF or Amyloidosis? The Right Therapies for Right Patients
Feat.
M. Kittleson
17:08
CVRx | Barostim
Integrating Barostim into a Comprehensive Heart Failure Program ISHL…
Feat.
D. Yaranov,
P. Patel,
R. Gupta,
J. Schmitto,
E. Chung
18:48
Right Care Initiative
Precision Medicine in Menopause: How Times Have Changed!
Feat.
K. Adams
19:30
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
Feat.
N. Ibrahim
17:29
UCLA Health
Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics
Feat.
D. Vucicevic
12:09
ARCH Advanced Revascularization Symposium
End-Stage Heart Failure Therapies
Feat.
D. Horstmanshof
14:19
UChicago Medicine
S-QUAD Therapy and Beyond: HFpEF in 2024
Feat.
M. Belkin
17:22
Samuel Sherratt
Sotagliflozin, a Dual SGLT 1 and 2 Inhibitor, Has High Membrane Affi…
34:18
Scripps Health
Cancer Survivorship: How To Monitor for Cardiac Disease Following Tr…
Feat.
A. Kuo
12:30
Houston Methodist Hospital
Amyloidosis Types and Pathophysiology
Feat.
B. Trachtenberg
20:59
Mary E. Money
Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…
84:17
Jefferson Health
2022 Heart Failure Guidelines Review
Feat.
D. Haas
27:52
Top Ten Topics in Clinical Cardiology 2023
Medical Management of Diastolic Dysfunction: Does The Emperor Finall…
Feat.
S. Pinney
